While adherence is improving, we need more data to ensure these costly medications deliver long-term value for patients and the health care system. Doctors, patients frustrated Zepbound and Wegovy are both effective at treating obesity and approved by the FDA to do so, but there are differences
More recently, novel formulations of double and triple gut hormone receptor agonists (involving glucose-dependent insulinotropic polypeptide [GIP] and glucagon) have been successfully developed [4], and other hormones, such as oestrogens and thyroid hormones, have also shown potential for use as therapies for the treatment of diabetes
This can make a significant difference for individuals who struggle with maintaining stable blood sugar or controlling food intake
8-pCPT-2- O -Me-cAMP, a selective activator of Epac, stimulated PI hydrolysis, and GLP-1 and PYY release